ArticleJournal of computer-aided molecular design2026
Mixed-Solvent MD suite: modular tools for building and analyzing mixed-solvent molecular dynamics systems.
Article in Journal of computer-aided molecular design, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Mixed-solvent molecular dynamics (MSMD) has become a useful simulation strategy for mapping protein interaction hotspots, exploring cryptic or allosteric pockets, and characterizing ligandable surface regions. However, practical MSMD studies still require labor-intensive system preparation, probe bookkeeping, format conversion, and trajectory post-processing across multiple software environments. Here, we present the Mixed-Solvent MD Suite, a modular software platform that automates these operational steps rather than proposing a new physical sampling formalism. The Suite includes (1) a fully web-based Mixed Solvent MD System Builder for protein and probe setup, concentration-controlled solvation (% w/v or mol/L), and automated generation of GROMACS and AMBER compatible input files, and (2) a local Probe GridMap Builder for grid-based probe occupancy analysis of MD trajectories using the AMBER cpptraj backend. Case studies on five benchmark proteins show that the platform reproducibly constructs MSMD systems, supports transferable analysis workflows across simulation outputs, and qualitatively recovers known ligandable regions in representative targets. Overall, the Mixed-Solvent MD Suite lowers technical barriers for MSMD studies and provides an extensible foundation for future benchmarked hotspot analysis and cryptic-site discovery workflows.
Indexed as
Identifiers
42185685What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.